CD4 Lymphocyte Count
Research News and Information

Sunday, November 22, 2009

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

13 Nov 2009 BACKGROUND: The association between postnatal human immunodeficiency virus type 1 (HIV-1) transmission and maternal highly active antiretroviral therapy (HAART) after infant extended antiretroviral prophylaxis was assessed. METHODS: A follow-up ... Read more...

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

30 Oct 2009 BACKGROUND: Achieving virologic suppression is a clear therapeutic goal for patients receiving combination antiretroviral therapy (cART). However, the effects of immunologic responses, whether measured as CD4 count changes from baseline or CD4 ... Read more...

Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection.

30 Oct 2009 BACKGROUND: Boosted darunavir (DRV/r) plus etravirine (ETR), in DUET trials, and raltegravir, in BENCHMRK trials, showed high rates of virologic response in patients with multidrug-resistant HIV-1 infection, particularly when associated with two ... Read more...

Latest indexed articles for 'CD4 Lymphocyte Count'

These are the very latest articles for this heading:

• Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. 13 Nov 2009
• Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. 30 Oct 2009
• Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection. 30 Oct 2009
• Gender differences in discontinuation of antiretroviral treatment regimens. 30 Oct 2009
• Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005. 30 Oct 2009
• Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. 30 Oct 2009
• Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress. 30 Oct 2009
• Regulatory T-cells in periapical lesions. 30 Oct 2009
• Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. 14 Oct 2009
• Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression. 13 Oct 2009
• Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. 13 Oct 2009
• Interleukin-2 therapy in patients with HIV infection. 13 Oct 2009
• Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. 29 Sep 2009
• Uncontrolled HIV RNA, immunodeficiency, and malignancy: implications for cancer control. 29 Sep 2009
• The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. 29 Sep 2009
• Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone. 29 Sep 2009
• Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German Competence Network for HIV/AIDS. 26 Sep 2009
• Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. 21 Sep 2009
• Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis. 17 Sep 2009
• Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. 16 Sep 2009

See a longer list of these articles.

Technical information about 'CD4 Lymphocyte Count'

Definition: The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.

Descriptor UI: D018791

Alternative terms: CD4 Lymphocyte Count; Lymphocyte Count, CD4; CD4 Lymphocyte Counts; Lymphocyte Counts, CD4; CD4 Counts; CD4 Count; CD4 Cell Counts; CD4 Cell Count; CD4+ Cell Counts; CD4+ Cell Count; CD4+ Counts; CD4+ Count; T4 Lymphocyte Count; Count, T4 Lymphocyte; Counts, T4 Lymphocyte; Lymphocyte Count, T4; Lymphocyte Counts, T4; T4 Lymphocyte Counts;

Allowable Qualifiers: classification; economics; history; instrumentation; methods; standards; trends; utilization; veterinary; statistics & numerical data; ethics;

Tree Number: E01.450.375.107.595.500.150; E05.200.500.195.107.595.500.150; G04.170.107.595.500.150; G09.188.105.595.500.150;

History Note: 95

Technical Notes: usually NIM; coord with disease /immunol, not /physiopathol